BBI’s Scientific Director Dr. Jay Shendure and Principal Investigator Dr. Helen Chu briefed Washington Governor Jay Inslee on Friday (April 16th) on the institute’s work regarding the Seattle Flu Study, progress on studying COVID-19 transmission and variants, and other issues. Dr. Paul Ramsey, UW Medicine CEO, also participated in the 25-minute meeting at the UW Medicine Virology Lab in Seattle.…
Read More
Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance…
Read More
UW Medicine’s Chief Medical Officer Doctor Tim Dellit says the coronavirus variants can’t be taken lightly. What’s concerning is that more recently now, 70 percent of the COVID-19 tests that are taken to the University of Washington Virology Lab for genome sequencing are coming back as a variant of the virus. It’s showing that these variants are spreading faster and…
Read More
Seattle is one of four cities taking part in a new Phase One clinical trial for an updated coronavirus vaccine. The brand-new trial will test a Moderna vaccine that’s been slightly altered to better protect against the coronavirus variant first found in South Africa. The trial is taking place at Kaiser Permanente Washington Health Research Institute and joins other trials…
Read More
Identifying the precise genetic cause of a disease, especially a rare disease, is as complex as it is demanding. But for many of the estimated 30 million people in the U.S. dealing with one of more than 7,000 rare diseases, the work is essential. This is because – as an individual or his/her/their family who has an undiagnosed genetic disorder…
Read More
Defective freeloader viral genomes have been detected in infections by DNA viruses in humans for the first time, researchers at the University of Washington School of Medicine in Seattle report.  Defective viral genomes have been discovered previously in infections caused by RNA viruses. But never have they been reported in an infection by a DNA virus. The discovery suggests that…
Read More
A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease. Currently no cure exists for HIV and AIDS. But antiretroviral therapy drugs, or ARTs, effectively suppress the virus to undetectable levels, but when…
Read More
After 38 years with the department, Joseph M. Czerniecki, MD, MS, has retired from his regular faculty appointment in the Department of Rehabiliation Medicine and begun work in his new appointment as an active professor emeritus. Czerniecki began his career at VA Puget Sound Health Care System and as an acting assistant professor in the UW Department of Rehabilitation Medicine in 1986, following completion of…
Read More
With COVID-19 cases on the rise again in many parts of the country — including Washington state where three counties were pushed back to Phase 2 effective Friday — there’s a growing debate between continuing to give both doses of Moderna or Pfizer-BioNTech vaccines close together, or giving them months apart in order to get first shots in more shoulders…
Read More